9 results
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
prescribing and management ... in Pulmonary Arterial ... #prescribing #Pulmonary ... #Algorithm #treatment ... #pharmacology
An Algorithm for the Management of Seizures

The management of active seizures is algorithmic, starting with a
the Management ... Seizures The management ... and bag-valve mask ... Pharmacologic treatment ... #Management #Emergency
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... #Management #Pulmonary
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... Obstructive Pulmonary ... #Algorithm #Management ... #Pulmonary #LABA ... SABA #SAMA #ICS #Pharmacology
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
Shock - Differential ... • Obstructive: Pulmonary ... Dehydration Shock Treatment ... #criticalcare #algorithm ... #treatment #management
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Intermediate Risk Pulmonary ... Algorithm Dr. ... Ryan @JJRyanMD #Pulmonary ... #Algorithm #treatment ... #pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... & Dry) is the treatment ... #diagnosis #differential ... #algorithm #management ... icu #clinical #pharmacology
There are similarities and differences between these 3 conditions which all carry treatment implications. Each mimic
which all carry treatment ... In both SK and AK ... #diagnosis #differential ... #algorithm #management ... #treatment #criticalcare
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... lubricants • Pharmacologic ... Rheumatology #Diagnosis #Management